The global estrogen replacement therapy market size was valued at USD 11.8 billion in 2025 and is projected to grow from USD 12.4 billion in 2026 to USD 18.4 billion by 2033, at a CAGR of 5.8% from 2026 to 2033. The market in North America dominated with a revenue share of 41.5% in 2025.... Read More »
July 2026The global hereditary angioedema therapeutics market size was valued at USD 3.6 billion in 2025 and is projected to grow from USD 4.1 billion in 2026 to USD 8.2 billion by 2033, at a CAGR of 10.4% from 2026 to 2033. The market in North America dominated with a revenue share of 39.5% in 2... Read More »
July 2026The global osteoarthritis injectable market size was valued at USD 8.2 billion in 2025 and is projected to grow from USD 8.7 billion in 2026 to USD 14.2 billion by 2033, at a CAGR of 7.2% from 2026 to 2033. The market in North America dominated with a revenue share of 58.6% in 2025. This... Read More »
July 2026The global pharmaceutical manufacturing market size was valued at USD 616.2 billion in 2025 and is projected to grow from USD 664.0 billion in 2026 to USD 990.6 billion by 2033, at a CAGR of 5.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.... Read More »
July 2026The global prediabetes market size was valued at USD 349.0 million in 2025 and is projected to grow from USD 385.0 million in 2026 to USD 730.0 million by 2033, at a CAGR of 9.6% from 2026 to 2033. North America dominated the prediabetes market with the largest revenue share of 41.2% in ... Read More »
July 2026The global opioid use disorder market size was valued at USD 6.0 billion in 2025 and is projected to grow from USD 6.8 billion in 2026 to USD 12.9 billion by 2033, at a CAGR of 9.5% from 2026 to 2033. North America dominated the global market with the largest revenue share of 68.8% in 20... Read More »
July 2026The global ankylosing spondylitis market size was valued at USD 6.1 billion in 2025 and is projected to grow from USD 6.5 billion in 2026 to USD 10.5 billion by 2033, at a CAGR of 7.0% from 2026 to 2033. North America dominated the market with the largest revenue share of 56.7% in 2025.... Read More »
July 2026The global myasthenia gravis treatment market size was estimated at USD 2.8 billion in 2025 and is projected to grow from USD 3.0 billion in 2026 to USD 5.1 billion by 2033, growing at a CAGR of 7.8% from 2026 to 2033. The North America market held the largest share of 50.7% of the globa... Read More »
July 2026The global gaucher disease drugs market size was valued at USD 1.8 billion in 2025 and is projected to grow from USD 1.9 billion in 2026 to USD 2.2 billion by 2033, growing at a CAGR of 2.3% from 2026 to 2033. North America dominated the gaucher disease drugs market with the largest reve... Read More »
July 2026The global dementia treatment market size was valued at USD 19.1 billion in 2025 and is projected to grow from USD 20.3 billion in 2026 to USD 34.0 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. North America dominated the market with the largest revenue share of 37.4% in ... Read More »
July 2026The global gastroesophageal reflux disease therapeutics market size was valued at USD 5.2 billion in 2025 and is projected to grow from USD 5.3 billion in 2026 to USD 6.1 billion by 2033, growing at a CAGR of 2.0% from 2026 to 2033. North America dominated the market with the largest rev... Read More »
July 2026The global biologics market size was valued at USD 626.2 billion in 2025 and is projected to grow from USD 691.1 billion in 2026 to USD 1319.5 billion by 2033, growing at a CAGR of 9.7% from 2026 to 2033. North America dominated the biologics market with the largest revenue share of 44.4... Read More »
July 2026The global hemophilia market size was valued at USD 15.1 billion in 2025 and is projected to grow from USD 16.1 billion in 2026 to USD 25.4 billion by 2033, growing at a CAGR of 6.7% from 2026 to 2033. North America dominated the market with the largest revenue share of 48.7% in 2025. Th... Read More »
July 2026The global inhalation & nasal spray generic drugs market size was valued at USD 32.6 billion in 2025 and is projected to grow from USD 35.3 billion in 2026 to USD 63.6 billion by 2033, growing at a CAGR of 8.8% from 2026 to 2033. North America dominated the market with the largest re... Read More »
June 2026The global insulin market size was valued at USD 19.3 billion in 2025 and is projected to grow from USD 19.4 billion in 2026 to USD 29.9 billion by 2033, growing at a CAGR of 6.4 % from 2026 to 2033. North America dominated the market with the largest revenue share of 44.0% in 2025. Adva... Read More »
June 2026The global anti-vascular endothelial growth factor therapeutics market size was valued at USD 14.5 billion in 2025 and is projected from USD 14.3 billion in 2026 to USD 11.8 billion by 2033, at a CAGR of -2.7% from 2026 to 2033. The market in North America dominated with a revenue share ... Read More »
June 2026The global huntington’s disease treatment market size was valued at USD 642.7 million in 2025 and is projected to grow from USD 868.2 million in 2026 to USD 2623.4 million by 2033, at a CAGR of 17.1% from 2026 to 2033. The market in North America dominated with a revenue share of 4... Read More »
June 2026The global cannabidiol market size was valued at USD 18.2 billion in 2025 and is projected to grow from USD 20.5 billion in 2026 to USD 39.7 billion by 2033, at a CAGR of 9.9% from 2026 to 2033. The market in North America dominated with a revenue share of 66.5% in 2025. The market is expected to grow with the ... Read More »
June 2026The global vaccine adjuvants market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.0 billion in 2026 to USD 6.0 billion by 2033, at a CAGR of 5.6% from 2026 to 2033. The market in North America dominated with a revenue share of 39.3% in 2025. The grow... Read More »
June 2026The global glioblastoma multiforme treatment market size was valued at USD 4.0 billion in 2025 and is projected to grow from USD 4.4 billion in 2026 to USD 7.9 billion by 2033, at a CAGR of 8.7% from 2026 to 2033. The market in North America dominated with a revenue share of 40.0% in 202... Read More »
June 2026